Key result
Ivabradine successfully resolves postural orthostatic tachycardia syndrome in a case report.
Why the study?
The etiology of postural orthostatic tachycardia syndrome (POTS) is complex and multifactorial, and ivabradine, which selectively inhibits If ion current in the sinoatrial node, has been reported to be useful alongside previously used beta blockers.
Case Report (n=1)
This case report describes a patient with postural orthostatic tachycardia syndrome (POTS) successfully treated with ivabradine.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for ivabradine in POTS; should not change practice without controlled trials.
Postural orthostatic tachycardia syndrome (POTS) is characterized by inappropriate increase in heart rate on assuming upright position from a supine position without a necessary drop in blood pressure. Etiology of this condition is complex and multifactorial. Autonomic dysfunction,[1] hypovolemia,[2] hyper responsiveness of beta adrenergic receptors[3] with associated elevations of plasma norepinephrine levels have been implicated as underlying pathophysiologic mechanisms. Beta blockers have previously been used to treat this condition. Ivabradine which selectively inhibits If ion current in the sino atrial node, has been reported to be useful in patients with POTS.[4,5] We present one further such case of POTS successfully treated by Ivabradine.
No takes yet. Share an insight, caveat, or question.
DV et al. (2010) conducted a case report in Postural orthostatic tachycardia syndrome (POTS) (n=1). Ivabradine was evaluated. Ivabradine successfully treated 1 patient with postural orthostatic tachycardia syndrome (POTS).
Synapse has enriched 10 related papers. Consider them for comparative context: